1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > United Kingdom Infectious Diagnostics Market Outlook to 2021

United Kingdom Infectious Diagnostics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 40 pages

United Kingdom Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "United Kingdom Infectious Diagnostics Market Outlook to 2021", provides key market data on the United Kingdom Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the United Kingdom Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United Kingdom Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Infectious Diagnostics Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Infectious Diagnostics Market, United Kingdom 7
3.1 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014 7
3.2 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021 9
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 13
3.3 Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in United Kingdom, Infectious Diagnostics Market 18
4.1 F. Hoffmann-La Roche Ltd. 18
4.1.1 Company Overview 18
4.2 Abbott Laboratories 18
4.2.1 Company Overview 18
4.3 Siemens Healthcare 18
4.3.1 Company Overview 18
4.4 Danaher Corporation 19
4.4.1 Company Overview 19
4.5 Becton, Dickinson and Company 19
4.5.1 Company Overview 19
4.6 Alere Inc. 19
4.6.1 Company Overview 19
4.7 Bio-Rad Laboratories, Inc. 20
4.7.1 Company Overview 20
5 Infectious Diagnostics Market Pipeline Products 21
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 33
6.1.2 Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 34
6.2 Venture Financing 35
6.2.1 Atlas Genetics Raises USD20 Million in Series C Financing 35
7 Appendix 37
7.1 Research Methodology 38
7.1.1 Coverage 38
7.1.2 Secondary Research 38
7.1.3 Primary Research 38
7.1.4 Company Share Analysis 39
7.1.5 Distribution Share Analysis 39
7.2 GlobalData Consulting 39
7.3 Contact Us 39
7.4 Disclaimer 40

1.1 List of Tables
Table 1: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Infectious Diagnostics Market Pipeline Products 21
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 33
Table 9: Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 34
Table 10: Atlas Genetics Raises USD20 Million in Series C Financing 35

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Infectious Diagnostics Market, United Kingdom, Company Share (%) 2014 16

Companies Mentioned
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
Danaher Corporation
Becton, Dickinson and Company
Alere Inc.
Bio-Rad Laboratories, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.